- Home
- CEE vs ANIX Comparison
CEE vs ANIX Comparison
Compare CEE & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEE
- ANIX
- Stock Information
- Founded
- CEE 1990
- ANIX 1982
- Country
- CEE Germany
- ANIX United States
- Employees
- CEE N/A
- ANIX N/A
- Industry
- CEE Finance Companies
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- CEE Finance
- ANIX Health Care
- Exchange
- CEE Nasdaq
- ANIX Nasdaq
- Market Cap
- CEE 105.5M
- ANIX 95.7M
- IPO Year
- CEE N/A
- ANIX 1987
- Fundamental
- Price
- CEE $15.06
- ANIX $4.36
- Analyst Decision
- CEE
- ANIX Strong Buy
- Analyst Count
- CEE 0
- ANIX 3
- Target Price
- CEE N/A
- ANIX $9.00
- AVG Volume (30 Days)
- CEE 22.0K
- ANIX 255.6K
- Earning Date
- CEE 01-01-0001
- ANIX 09-10-2025
- Dividend Yield
- CEE 3.86%
- ANIX N/A
- EPS Growth
- CEE N/A
- ANIX N/A
- EPS
- CEE N/A
- ANIX N/A
- Revenue
- CEE N/A
- ANIX N/A
- Revenue This Year
- CEE N/A
- ANIX N/A
- Revenue Next Year
- CEE N/A
- ANIX N/A
- P/E Ratio
- CEE N/A
- ANIX N/A
- Revenue Growth
- CEE N/A
- ANIX N/A
- 52 Week Low
- CEE $7.80
- ANIX $2.07
- 52 Week High
- CEE $10.32
- ANIX $4.98
- Technical
- Relative Strength Index (RSI)
- CEE 37.94
- ANIX 64.72
- Support Level
- CEE $14.76
- ANIX $3.21
- Resistance Level
- CEE $15.88
- ANIX $4.98
- Average True Range (ATR)
- CEE 0.42
- ANIX 0.28
- MACD
- CEE -0.02
- ANIX 0.12
- Stochastic Oscillator
- CEE 30.28
- ANIX 60.54
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.